Despite a significant net loss, GRAIL Inc (GRAL) reports strong revenue growth and strategic collaborations, setting the stage for future advancements.

The local sector of test makers, specialized equipment manufacturers and testing product suppliers remain invested in their ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 19, 2025 /PRNewswire/ -- USA News Group News Commentary - Amid the excitement surrounding ...

Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.

Workers at B.C.’s LifeLabs have begun a series of rolling strikes that could lead to the closure of some laboratories.

Last week Pfizer announced that Ian Read is to step down as CEO, with chief operating officer ... Currently chief information officer at Quest Diagnostics, Fonseca will join Pfizer’s executive ...

The Robert De Niro-led Netflix conspiracy thriller has noble ambitions but an unsatisfactory message. Here's what happens in ...

Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tony Remington, CEO and founder of Gravity Diagnostics, said in an email to the Business Courier the company is investing heavily in its revenue cycle management infrastructure, expanding its ...

Reports Q4 revenue $38.3M vs. $30.3M last year. “2024 was a transformational year for GRAIL (GRAL) as we completed the separation from Illumina ...